Needle Localization During Prostate Brachytherapy Using Power Doppler Ultrasound
About This Trial
- This study is testing a new ultrasound technique that uses gentle vibrations to help doctors see needles more clearly during prostate cancer treatment.
- The goal is to improve how accurately these needles are placed when delivering internal radiation therapy directly to the tumor.
- It is open to adults with prostate cancer who are already planning to receive this standard radiation procedure as part of their care.
- Before considering the study, patients should know that they cannot take part if they have previously received radiation therapy to the prostate.
More Information
- This study involves patients who are scheduled for standard care brachytherapy of focal tumours within the prostate, which is normally performed under standard 2-dimensional (2D) ultrasound guidance.
- The purpose of this study is the acquire power Doppler ultrasound while using a simple oscillator in physical contact with the end of a brachytherapy needle.
- The vibrations along the needle should be visible in the power Doppler ultrasound, helping to visualize the needle position within the anatomy.
Who Can Enroll
- Age Range: 18 years and older
- Gender: Male
- Who This Trial is For: This study is testing a new ultrasound technique that uses gentle vibrations to help doctors see needles more clearly during prostate cancer treatment.
Study Details
- Start Date: March 4, 2020
- Lead Sponsor: Western University, Canada
Full Eligibility Criteria
Inclusion Criteria
- Male, aged 18 years or older
- Willing to provide written consent
- Pathologically confirmed prostate cancer on previous biopsy
- Suitable for and consenting to high-dose-rate brachytherapy for treatment as Standard of Care.
Exclusion Criteria
- • Previous radiotherapy to the prostate
Treatments
- Device: Prostate Brachytherapy